Farnaz Zahedi Avval

5PUBLICATIONS
7CO-AUTHORS
Genome structure and regulationMolecular targetsPredictive and prognostic markersAllergyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 02, 2022
Glutathione reductase system changes in HTLV-1 infected patients.

Sajad Ehtiati, Masoud Youssefi, Houshang Rafatpanah

|Dec 20, 2021
Aprepitant Promotes Caspase-Dependent Apoptotic Cell Death and G2/M Arrest through PI3K/Akt/NF-κB Axis in Cancer Stem-Like Esophageal Squamous Cell Carcinoma Spheres.

Hossein Javid, Amir R Afshari, Farnaz Zahedi Avval

|Dec 04, 2021
Total antioxidant capacity as a marker of severity of COVID-19 infection: Possible prognostic and therapeutic clinical application.

Neda Yaghoubi, Masoud Youssefi, Farahzad Jabbari Azad

|Jun 05, 2021
Evaluation of glutathione reductase activity in colon tissue of patients with irritable bowel syndrome.

Shima Lorestani, Ali Bahari, Mahdi Asadi

|Nov 30, 2018
Thioredoxin reductase gene expression and activity among human T-cell lymphotropic virus type 1-infected patients.

Neda Yaghoubi, Masoud Youssefi, Seyed Isaac Hashemy

Pageof 1

Frequent Collaborators

2 joint publications

Masoud Youssefi

2 joint publications

Seyed Isaac Hashemy

2 joint publications

Houshang Rafatpanah

2 joint publications

Baratali Mashkani